A New Dawn for Bladder Control: Medtronic's Altaviva and BlueWind's Revi Promise Life-Changing Freedom
Medtronic Secures $1.5 Billion in Senior Notes: Fueling Future Growth and Strategic Initiatives
Medtronic's Protracted Stagnation: Unraveling 1,100 Days of Flat Performance and What Lies Ahead
Orchestra BioMed: Revolutionizing MedTech with a Big Pharma Playbook
Unlocking Value: Why Analysts See Further Divestitures on Medtronic's Horizon
Midday Market Movers: Unpacking the Forces Behind Today's Top Stock Swings
Medtronic Soars: Upgraded Outlook & Bold Board Moves Signal New Era Post-Elliott